About this event
The NHS committed itself to become the ‘world’s first net zero national health service’
Find out more in part two of The Sustainability Series
The NHS committed itself to become the ‘world’s first net zero national health service’ setting out ambitious targets to achieve this objective in Delivering a ‘Net Zero’ National Health Service (October 2020).
For emissions that the NHS controls directly, it will reach net zero by 2040, and for emissions the NHS can influence by 2045.
Realising this in as complex a system as the NHS is particularly challenging and necessitates immediate and ongoing action that will affect all aspects of service delivery.
Key areas critical to carbon reduction have been red flagged, including:
Carbon-literacy will be essential to commercial success for Pharma and MedTech, with a demonstrable commitment to sustainability and change acting as a gatekeeper to the supply of medicines and medical equipment.
In this important event, our experts will clearly explain what needs to be done now and how industry can positively engage with the net-zero challenge.
The NHS acknowledges that it cannot succeed in its ambitions without the support of all of its suppliers and partners. This event will show you how to identify mutually beneficial opportunities and to become a part of the solution.
Derek is an entrepreneurial international executive with extensive experience of commercial management, sales and marketing, supply chain and developing strategies to bring complex products to market. Derek joined the pharmaceutical Industry in 1988 and has worked for some of the largest companies in the proprietary and generic sectors. He set up his own consultancy practice in 2019 which has now expanded to have high level engagement with companies operating in early-stage Phase 1 clinical trials through to helping pharma companies including Top 3 firms amplify their commercial portfolio strategies. Derek is committed to proactivily working with his affiliates and in addition supporting the NHS to develop the best partnership solutions across several key areas.
Michelle has had a diverse career in pharmaceutical and medical devices, first working in the industry in 1990. As a lateral thinker and strategist, her employers such as Covidien/Medtronic, and Boston Scientific, have often created roles to capitalise on her knowledge and skills, helping them to respond to the prevailing market conditions. A graduate biologist with a long-standing career in sales, management, marketing, and market development, Michelle chose to re-train in Health Economics at York University, adding the value ‘spectacles’ and ‘hearing-aids’ she employs today when working with the business leaders of her current employer, their customers (the NHS), and various industry bodies. Her current in-depth understanding of COVID and its implications, has led to a dedicated following on Linked-in, and a focus on how we can best work and show unique value in the new ‘COVID-WORLD’ that is upon us.
Ian co-founded the Life Science Access Academy with Nigel Robbins to bring together all the best ideas in people development from more than 20 innovative specialist consultancies.
LSAA is a truly Global Membership Community for all staff from across the Life Science sector including: commercial, clinical and financial sales teams, medics and support teams.
Share this event